EP
Eupraxia Pharmaceuticals Inc.
EPRX · NASDAQ
$8.42 +3.44% (+$0.28)
1M +23.46%
Market Cap $281.9M
P/E Ratio -
Div. Yield -
ROE 43.59%
Bulios Fair Price
$6.33
24.8% downside
Trenutna cena
$8.42
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica EPRX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
84 /100
Cheap P/B 2.15x
PEG N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 98.17%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 34.41%
ROIC 43.20%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 16.00x
Debt/Equity 0.01x
Debt/Assets N/A
Stability
42 /100
Moderate Profitable years 0
Beta 1.50x
EPS volatility 28.50%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EPRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James A. Helliwell
Employees
49
Headquarters
Victoria
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report